Navigation Links
Pharmaceutical Launch Excellence Services Delivers Market Entry Road Map
Date:3/4/2011

CHAPEL HILL, N.C., March 4, 2011 /PRNewswire/ -- The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs.

Facing an ever-changing launch landscape, product launch leaders are looking to guard against uncertainty as they guide new therapies through the labyrinth of regulatory and marketplace challenges.

To that end, Best Practices, LLC has collected hundreds of best practices, narratives, and metrics around the issue of new product launch. To provide launch executives with the critical information they need to succeed with a product launch, we have consolidated our best launch research and services into the Pharmaceutical Launch Excellence Services.

The Launch Excellence Services product connects launch professionals to benchmarking and networking solutions to address a variety of mission-critical issues, including:

  • Spend across launch activities
  • Differentiating a new product from competitors
  • Portfolio decisions
  • Timing and value of different new product planning activities
  • Coordinating Regional and Global launch activities
  • Strength and weakness of various structural approaches for new product planning
  • Balancing development and commercial interests
  • Brand team responsibilities
  • Use of public relations to support launch

Pharmaceutical executives will find the primary and secondary research information provided in this product essential for identifying trends, gaining a better understanding of the market and ensuring a strong market entry for new products.

To explore the Pharmaceutical Launch Excellence Services in greater detail, download our complimentary research excerpt at http://www3.best-in-class.com/or2.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For more than 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.  For more information about the company, go to www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
2. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
3. Endo Pharmaceuticals Launches FORTESTA™ (Testosterone) Gel for Topical Use Class III for Adult Men in the U.S. With Low Testosterone
4. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
5. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
6. Onyx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
7. Savient Pharmaceuticals to Present at the 31st Annual Cowen & Co. Health Care Conference
8. Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.
9. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
10. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
11. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... 2017  New York City-based market research firm Kalorama Information ... aware of.  From new products to new costs, to the ... recently completed study, Potential Pipeline Disruptors . ... 1.  Age-Driven Growth - True Impact Moment Arriving ... the impact the growing population and, to a more extreme ...
(Date:7/11/2017)... ROCKVILLE, Md. , July 11, 2017  The ... had estimated revenues of approximately $394.1 million in 2016.  ... a trend of solid growth, in particular as a ... oncology clinical practice, and the recent introduction of a ... the need for less-invasive testing of tumor biomarkers to ...
(Date:7/10/2017)... GAITHERSBURG, Md. , July 10, 2017 ... in non-animal test methods, is the recipient of a ... by the PETA International Science Consortium. The device, which ... be used to expose human lung cells to airborne ... lung. IIVS will use the VITROCELL® system for testing ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... 21, 2017 , ... The Margarian Law Firm has filed a class ... ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand of ... Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it is made ...
(Date:7/21/2017)... ... July 21, 2017 , ... “Kids aren't born knowing how to ... shoes,” says Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To ... Kickstarter on Monday, July 21st. , The kit uses colorful, engaging and educational ...
(Date:7/21/2017)... CANADA (PRWEB) , ... July 21, 2017 , ... ... torn anterior cruciate ligament (ACL) offer patients improved quality of life five years ... for Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. The study followed ...
(Date:7/20/2017)... Boston, MA (PRWEB) , ... July 20, 2017 ... ... aggressive form of blood and bone marrow cancer that progresses rapidly without treatment. ... often recommended to reduce the chance of reoccurrence and relapse. With such ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... in which their iMedSecure™ comes included with each system installation. RMT’s iMedHD2™ ... to remote participants for real-time collaboration and immediate decision-making requirements. While never ...
Breaking Medicine News(10 mins):